Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Will The Anti-Hypertensive Drugs Market Valuation Change Between Now And 2029?

Over the past few years, the market size for anti-hypertensive drugs has seen a moderate rise. The progression from $37.42 billion in 2024 to $38.03 billion in 2025, promising a compound annual growth rate (CAGR) of 1.6%, can be expected. This growth during the historic period is due to variables such as environmental factors, lifestyle changes, prior market competition, traditional treatment choices, economic circumstances, and global health trends from the past.

In the coming years, the market size for anti-hypertensive drugs is predicted to experience a slight increase, reaching a value of “$40.74 billion in 2029 at a compound annual growth rate (CAGR) of 1.7%. Factors such as affordability and cost-effectiveness, groundbreaking therapeutic advancements, epidemiological patterns, regulatory modifications and approvals, demographic changes due to an aging population, and alterations in healthcare policies and reimbursements contribute to this predicted growth. The forecast period will likely see key trends including therapeutic innovation, epidemiological changes, shifts in the regulatory environment, modifications in healthcare policies, and advancements in diagnostic and monitoring mechanisms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Which Industry Forces Are Driving The Anti-Hypertensive Drugs Market Forward?

The rise in the anti-hypertensive drug market is majorly propelled by a sedentary lifestyle. Factors such as junk food consumption, an imbalance in a healthy diet, and improper sleep patterns due to erratic work schedules contribute to the escalation of hypertension. It is the key element behind about 45% of heart disease-related deaths and 51% of stroke-related deaths. Upon diagnosis of hypertension, patients must take medication according to the severity of their condition. For example, as per the National Health Service in England in May 2023, the incidence of total hypertension elevates with age. It begins at 9% amongst adults aged 16 to 44 and rises to 60% in individuals aged 65 and above. This results in a consistent demand for these drugs and serves as a significant catalyst for the market growth.

What Are The Key Segment Trends Observed In The Anti-Hypertensive Drugs Market?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

Which Disruptive Trends Are Driving Change Across The Anti-Hypertensive Drugs Market?

Leading businesses in the anti-hypertensive drugs industry are concentrating on developing new offerings such as Metoprolol Succinate Extended-Release Tablets to gain a competitive advantage. Used for treating hypertension patients, these tablets serve as an effective anti-hypertensive medication. In a remarkable development in June 2023, Metoprolol Succinate Extended-Release Tablets, manufactured by Granules India Limited, a pharmaceutical firm based in India, received approval from the Food and Drug Administration (FDA), an American federal institution. This innovative medication is engineered specifically to manage hypertension and lower blood pressure levels. Available in dosages ranging from 25mg to 200mg, this drug is a beta-blocker that slows the heart rate, lessens the heart’s burden, and consequently drops high blood pressure levels.

Who Are The Leading Companies Driving The Anti-Hypertensive Drugs Market?

Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Which Region Is Forecasted To Lead The Anti-Hypertensive Drugs Market In The Coming Years?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model